Description

CID-0-RAB DSR TAB is a dual-layer, sustained-release gastrointestinal tablet formulated with Domperidone SR and Rabeprazole EC (enteric-coated). It is used to manage acid-related disorders such as gastroesophageal reflux disease (GERD), chronic acidity, gastritis, and functional dyspepsia.

Mechanism of action:

• Rabeprazole: A proton pump inhibitor (PPI) that reduces gastric acid secretion by inhibiting the H⁺/K⁺ ATPase enzyme in stomach parietal cells

• Domperidone SR: A dopamine antagonist that enhances gastrointestinal motility and prevents nausea, bloating, and reflux by promoting faster gastric emptying

Therapeutic benefits:

• Sustained relief from heartburn and acid reflux

• Reduces symptoms of indigestion, bloating, and stomach discomfort

• Supports long-term healing of gastric and duodenal ulcers

• Improved bioavailability with dual-release technology

Ideal for once-daily dosing, CID-0-RAB DSR TAB is well-tolerated and ensures long-lasting symptom control in patients with chronic gastrointestinal issues.

Manufactured under WHO-GMP and ISO-certified facilities, CID-0-RAB DSR TAB is represented by BLUEPILL EXPRESS, a global exporter of high-quality pharmaceutical medicines. BLUEPILL EXPRESS delivers internationally to Asia, Africa, Europe, the Middle East, and the Americas, ensuring quality, compliance, and on-time delivery.